Here are three key notes:
1. The system is a minimally invasive interbody fusion device providing integrated fixation.
2. The system is designed for use in patients with degenerative disc disease at 1 or 2 contiguous levels from L2 to S1.
3. The system is intended for use with bone graft and with supplemental fixation systems.
More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
